Dana-Farber Cancer Institute /ID# 218010

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Myelofibrosis (MF)

Studies at this site

• Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis — Completed